Cytology of Bone Tumors and Pseudotumors
Yaxia Zhang, MD, PhD
Bone tumor is rare and diagnostically challenging. This interactive and case based lecture will provide basic and advanced information on bone tumor morphology, classification, ancillary testing, biomarkers and clinicoradiological information to highlight the diagnostic, prognostic and therapeutic implications of bone tumors. Representative tumors of bone in osseous, cartilaginous, small blue round cell, spindle cell, giant cells rich, and other morphology will be addressed. Differential diagnosis, pertinent ancillary testing, and diagnostic pitfall will be discussed. Practicing pearls of how to perform appropriate on-site evaluation and triage of bone specimens to facilitate an accurate diagnosis will be also discussed. The attendees will have a much better understanding of how to achieve a timely, accurate and specific diagnosis of common and difficulty bone tumors for better patient care.
This educational activity is designed for pathologists, cytopathologists, cytotechnologists, students and other members of the cytopathology community.
- Discuss the pathogenesis, classification and clinicoradiological features of bone tumors
- Discuss the cytological features of bone tumors in osseous, cartilaginous, small blue round cell, spindle cell, giant cells rich, and other morphology
- Discuss the differential diagnosis, ancillary testing, and diagnostic pitfalls
Current ACCME guidelines state that participants in CME activities should be made aware of any affiliation or financial interest that may affect the speaker’s presentation(s). Therefore, it is the policy of the ASC to insure balance, independence, objectivity, and scientific rigor in all its educational programs. All planning individuals participating in any ASC Educational Activity are expected to disclose to the program audience any real or apparent conflict(s) of interest that may have a direct bearing on the subject matter of the continuing education program. Click here for a complete list.
Yaxia Zhang, MD, PhD
The presenter has no conflicts of interest or financial relationships to disclose.
ACCREDITATION AND DESIGNATION STATEMENTS
Continuing Medical Education (CME) Statement
The American Society of Cytopathology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The American Society of Cytopathology designates this enduring educational activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
American Board of Pathology Maintenance of Certification (MOC)
This product can help fulfill the CME requirements and Self-Assessment Modules (SAMs) mandated by the American Board of Pathology Maintenance of Certification (MOC) process. Earn up to 2.0 SAM Credit Hours.
Continuing Medical Laboratory Education (CMLE)
The ASC designates this activity for a maximum of 2.0 Continuing Medical Laboratory Education (CMLE) credit hours for non-physicians. The CMLE credit hours meet the continuing education requirements for the ASCP Board of Registry Certification Maintenance Program. Participants should claim only the credit commensurate with the extent of their participation in the activity.
Cytotechnologists with Licenses in Florida and California
This program is approved for 2 continuing education credits in the State of Florida and 1 in the State of California. The credit on each link is good for three years from the live presentation date.
- 2.00 AMA PRA Category 1 Credit™
- 1.00 California Credits
- 2.00 CMLE
- 2.00 Florida Credits
- 2.00 MOC II
- 2.00 Participant